Supplementary Figure 5 from LOX Inhibition Disrupts a Collagen–Integrin–MYC Axis to Suppress Progression of Invasive Lobular Carcinoma
Renée L. Flaherty, Flavia Hughes, George Sflomos, Carlos Ronchi et autres
0 citations
Wolfgang Jarolimek
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
92Publications signalées
4535Citations signalées
2Affiliations récentes
Les institutions déclarées
Les domaines associés
Microbial metabolism and enzyme functionIon channel regulation and functionNeuroscience and Neuropharmacology ResearchCell Adhesion Molecules ResearchEosinophilic Disorders and Syndromes
Les publications récentes
Supplementary Figure 6 from LOX Inhibition Disrupts a Collagen–Integrin–MYC Axis to Suppress Progression of Invasive Lobular Carcinoma
Renée L. Flaherty, Flavia Hughes, George Sflomos, Carlos Ronchi et autres
0 citations
Data from LOX Inhibition Disrupts a Collagen–Integrin–MYC Axis to Suppress Progression of Invasive Lobular Carcinoma
Renée L. Flaherty, Flavia Hughes, George Sflomos, Carlos Ronchi et autres
0 citations
Supplementary Figure 2 from LOX Inhibition Disrupts a Collagen–Integrin–MYC Axis to Suppress Progression of Invasive Lobular Carcinoma
Renée L. Flaherty, Flavia Hughes, George Sflomos, Carlos Ronchi et autres
0 citations
Supplementary Figure 4 from LOX Inhibition Disrupts a Collagen–Integrin–MYC Axis to Suppress Progression of Invasive Lobular Carcinoma
Renée L. Flaherty, Flavia Hughes, George Sflomos, Carlos Ronchi et autres
0 citations
Supplementary Figure 1 from LOX Inhibition Disrupts a Collagen–Integrin–MYC Axis to Suppress Progression of Invasive Lobular Carcinoma
Renée L. Flaherty, Flavia Hughes, George Sflomos, Carlos Ronchi et autres
0 citations
Supplementary Figure 3 from LOX Inhibition Disrupts a Collagen–Integrin–MYC Axis to Suppress Progression of Invasive Lobular Carcinoma
Renée L. Flaherty, Flavia Hughes, George Sflomos, Carlos Ronchi et autres
0 citations
LOX Inhibition Disrupts a Collagen–Integrin–MYC Axis to Suppress Progression of Invasive Lobular Carcinoma
Renée L. Flaherty, Flavia Hughes, George Sflomos, Carlos Ronchi et autres
gb, ch, au (code pays fourni par la source)
1 citation
Cancer Research
Matrix structure and microenvironment dynamics correlate with chemotherapy response in ovarian cancer
Florian Laforêts, Panoraia Kotantaki, Samar Elorbany, Joseph Hartlebury et autres
gb, au (code pays fourni par la source)
1 citation
iScience
Lysyl oxidases directly control cell surface abundance of platelet-derived growth factor receptors and signaling in osteoblasts
Wolfgang Jarolimek, Jessica Stolp, Lara Perryman, Nasi Huang et autres
gb, us (code pays fourni par la source)
0 citations
Blood
A phase 1/2a trial of amsulostat, a novel pan-lysyl oxidase inhibitor, in patients with advanced myelofibrosis as an add-on to ruxolitinib treatment for up to 52 weeks
Ross Baker, Chih‐Cheng Chen, Tsai‐Yun Chen, Stanley Cheung et autres
au, tw, kr, gb, us (code pays fourni par la source)
1 citation
Blood
A randomized, double-blind, placebo-controlled phase 1 trial of the topical pan–lysyl oxidase inhibitor PXS-6302 in mature scars
Natalie Morellini, Peijun Gong, Suzanne Rea, Helen E. Douglas et autres
au, cn, pl (code pays fourni par la source)
3 citations
Science Translational Medicine
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.